ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,289 | -57.2% | 84 | -40.8% | 0.00% | – |
| Q2 2023 | $5,342 | -78.6% | 142 | -74.6% | 0.00% | -100.0% |
| Q1 2023 | $24,920 | +166033.3% | 560 | +69.2% | 0.00% | – |
| Q4 2022 | $15 | -99.9% | 331 | +5.4% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 314 | +0.6% | 0.00% | – |
| Q2 2022 | $14,000 | -51.7% | 312 | -52.4% | 0.00% | – |
| Q1 2022 | $29,000 | +2800.0% | 655 | +6450.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 10 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2020 | $2,000 | -94.4% | 38 | -95.5% | 0.00% | -100.0% |
| Q3 2020 | $36,000 | +89.5% | 850 | +112.5% | 0.00% | 0.0% |
| Q2 2020 | $19,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |